Iku Shirasugi

6PUBLICATIONS
51CO-AUTHORS
Respiratory diseasesAutoimmunityPodiatryClinical pharmacology and therapeuticsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 28, 2026
Renal function-adjusted initial JAK inhibitor dosing and outcomes in rheumatoid arthritis: from the ANSWER cohort study.

|Jul 12, 2026
Successful salvage treatment with baricitinib for macrophage activation syndrome complicating adult-onset Still's disease during interleukin-6 inhibition: A case report and literature review.

|Jun 19, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort study.

|Apr 01, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Yuki Etani, Yasutaka Okita, Kohei Tsujimoto

|Jul 01, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study.

Kosuke Ebina, Yuki Etani, Yasutaka Okita

|Mar 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.

Kohei Tsujimoto, Kosuke Ebina, Satomi Okamura

Pageof 1

Frequent Collaborators

5 joint publications

Kosuke Ebina

5 joint publications

Motomu Hashimoto

5 joint publications

Wataru Yamamoto

4 joint publications

Koichi Murata